ReviewInternational journal of dermatology2026
Gonorrhea Management in High-, Limited- and No-Resource Settings: Implications in the Context of Antimicrobial Resistance.
Review in International journal of dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Antigonococcal Activity and Cytotoxicity Screening of Three Ziziphus Species Indigenous to South Africa.Chemistry & biodiversity · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Gonorrhea, a common sexually transmitted infection caused by Neisseria gonorrhoeae, represents an escalating global public health threat due to antimicrobial resistance. The current review explores diverse approaches around the globe to gonorrhea management across various settings, with a focus on diagnostic strategies, treatment practices, resistance surveillance, and new trends, such as point-of-care tests or doxycycline post-exposure prophylaxis. High-resource settings benefit from proper infrastructure, advanced diagnostics, screening programs, surveillance, access to effective treatment, and test-of-cure protocols. Nonetheless, rising incidence and resistance rates persist. In contrast, limited-resource settings often depend on syndromic management, which lacks sensitivity and fails to identify asymptomatic infections. The low diagnostic capacity and poor access to resistance-guided therapy contribute to inappropriate antimicrobial use. Migrants, incarcerated individuals, and those in vulnerable contexts face additional barriers. These disparities undermine the global control efforts and enable the emergence of drug-resistant strains. Addressing these gaps requires a multifaceted, equity-focused approach: strengthening diagnostic capacity, expanding access to molecular testing and surveillance, tailored interventions for the local contexts, and promoting antibiotic stewardship in both policy and practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.